Form 4: Emergent BioSolutions SVP William Hartzel Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
William Hartzel, SVP of Bioservices at Emergent BioSolutions, disposed of 292 shares of common stock on March 5, 2025, to cover tax obligations related to vesting and settlement of restricted stock units.
Summary
- On March 5, 2025, William Hartzel, SVP of Bioservices at Emergent BioSolutions, reported a transaction involving the disposal of 292 shares of common stock.
- The disposal was executed to cover tax obligations associated with the vesting and settlement of restricted stock units.
- Following the transaction, Hartzel directly owns 47,183 shares of Emergent BioSolutions common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily indicate a positive or negative outlook on the company.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. They are closely watched by investors seeking insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of stock disposal transaction. |
| 03/07/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.